InflaRx
IFRX
62 hedge funds and large institutions have $212M invested in InflaRx in 2026 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 3 closing their positions.
1,168% more call options, than puts
Call options by funds: $913K | Put options by funds: $72K
1,153% more capital invested
Capital invested by funds: $16.9M → $212M (+$195M)
900% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 3
104.54% more ownership
Funds ownership: 26.11% → 130.65% (+105%)
77% more funds holding
Funds holding: 35 → 62 (+27)
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$28.2M |
| 2 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$27.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.3M |
| 4 |
CC
Commodore Capital
New York
|
+$13.7M |
| 5 |
SSC
Spruce Street Capital
New York
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$1.77M |
| 2 |
EP
Eversept Partners
New York
|
-$854K |
| 3 |
Morgan Stanley
New York
|
-$488K |
| 4 |
Squarepoint
New York
|
-$230K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$114K |
IFRX Hedge Fund Activity: Q2 2026 in Review
62 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in InflaRx (IFRX) for Q2 2026, worth a combined $212M — up 1,153% from $16.9M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new IFRX positions and 3 closed out — a net gain of 27 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $28.2M. The largest seller was Bank of America, exiting entirely with an estimated $1.77M sold.
- 62 institutional investors held InflaRx (IFRX) as of Q2 2026, up from 35 in Q1 2026.
- Funds reported $212M of InflaRx stock for Q2 2026, up 1,153% quarter-over-quarter.
- 30 funds opened new InflaRx positions in Q2 2026 and 3 closed out, a net change of +27 holders.
- The largest InflaRx buyer in Q2 2026 was Suvretta Capital Management, an estimated $28.2M added.
- The largest InflaRx seller in Q2 2026 was Bank of America, an estimated $1.77M sold.
Based on aggregated 13F filings for Q2 2026.